BioNTech (BNTX) CEO Ugur Sahin Sells 76,500 Shares

What Happened

• Ugur Sahin, CEO of BioNTech SE (BNTX), sold a total of 76,500 shares in two open-market transactions. On 2026-09-03 he sold 45,000 shares at $102.85 each (proceeds $4,628,232). On 2026-09-04 he sold 31,500 shares at $103.52 each (proceeds $3,260,823). These were sales (not purchases), which are often routine insider liquidity events and do not by themselves indicate a change in company outlook.

Key Details

• Transaction dates and prices: 2026-09-03 — 45,000 shares @ $102.85; 2026-09-04 — 31,500 shares @ $103.52.
• Total shares sold: 76,500; total proceeds: $7,889,055.
• Plan/footnote: Sales were effected pursuant to a Rule 10b5-1 trading plan established by Sahin on June 3, 2026 (prearranged plan).
• Shares owned after transaction: Not specified in the provided excerpt — see the full Form 4 for post-transaction holdings.
• Filing: Form 4 dated/filed 2026-09-08 (reporting period begins 2026-09-03). Check the full filing for any timeliness flag or additional notes.

Context

• A 10b5-1 plan lets insiders sell on a preset schedule or conditions and is commonly used to avoid accusations of trading on material nonpublic information. Sales under such plans are typically considered routine liquidity rather than a direct signal about company fundamentals. Retail investors should view this as insider selling but consult the full Form 4 for ownership detail and any additional disclosures.